top of page

The Vitals: Breakthrough Materials, New Coatings, Innovative Surgical Robots, and Jason Scherer Workshop

Updated: Dec 9

New Bioabsorbable Material to Revolutionize Medical Device Innovation


new bioabsorbable material

Researchers have developed an entirely new material that could revolutionize multiple industries (Yahoo Tech). This innovative material can be charged like a battery to store energy or record digital information. Imagine shirts with built-in air conditioning or surgical implants that feel just like real tissue. 


While similar materials exist, they are often rigid and rely on toxic or rare components. This new material's unique structure is not only safer but also highly energy-efficient—an essential feature in today’s increasingly energy-demanding world.


President of R&D & Engineering Rich Thompson POV: At VitaTek, we are always looking for new materials or processes to improve our devices.  


Whether it’s bioabsorbable materials that eliminate the need to remove an implanted device, alternatives to silicone that are cheaper and easier to mold, or utilizing over-molding to mold a soft gasket right on the part to eliminate an extra component, we always look for ways to make a medical device better.


 

There's a New Coating in Town


new coating to revolutionize blood-contacting devices

There’s a new coating in development—one that could revolutionize the safety of blood-contacting devices like catheters, stents, and dialysis machines (Today's Medical Developments).


By mimicking the natural behavior of blood vessels, this innovative material addresses the significant concern of blood clotting. 


Currently, patients often rely on blood thinners before and after procedures, which increases the risk of dangerous bleeding. This new coating eliminates that concern by promoting normal blood flow, offering a safer solution for patients.


RVP of Sales Kristian Killian POV: With each passing month, coating advancements continue to develop to improve clinical outcomes for many patients. This is especially significant as more procedures are performed in Cath Labs and Interventional Radiology (IR).


To support this rapid progress, VitaCoat has been launched as an Open-Source Coating, enabling companies to innovate collaboratively on enhancements like bleeding prevention, bacterial reduction, and other clinical advancements.


Our Open-Source Hydrophilic Coating offers endless possibilities to these companies with access to resources at just a click of a button.


 

Featured Innovation: Momentis Surgical’s Novel Gynecological Surgical Robot


Momentis Surgical gynecology medical robot

Momentis Surgical has been granted 510k clearance for a second-generation surgical gynecology robot (Medical Device Network).


The newest model of the Anovo robotic surgical platform is the first FDA-cleared robotic system capable of operating in both retroflexion and anteflexion in uterine procedures.


The long-term goal is to expand its applications to other fields including general surgery and to break into markets in Europe and Asia.


CEO Jason Scherer POV: We love seeing companies push boundaries through technological advancements while establishing a strong foothold in the U.S. market.


In my opinion, the first ten years on the market should focus on solidifying market share within the U.S. before expanding internationally to avoid wasting your money -- unless you have a large budget specifically allocated for breaking into international markets.


 
catch up with vitatek

VitaTek CEO Jason Scherer live workshop on medical device mistakes

Join us for a one-hour live workshop where CEO Jason Scherer will walk through his three biggest mistakes when developing a medical device and how it led to bringing all development services in-house. 


Jason will break down his biggest obstacles when developing a medical device and how bringing everything in-house solves the many setbacks medical device inventors face. 


The workshop will consist of a short presentation of Jason’s background and end with a 30-min Q&A session.


Thursday, December 5th


1PM EST / 12PM CST / 11AM MST / 10AM PST


 

Comments


bottom of page